2024 Financial Report | Insulin Low Price Competition, Gan Li Pharmaceutical's Gains and Losses

Go out to sea

wallstreetcnApr 25 23:02 ET

Is the healthcare market recovering? Mindray Healthcare acquires control of Whitney Healthcare at 25% premium | Insight Research

In the new year, A was born, and the leading device company Mindray entered the cardiovascular field at a premium.

wallstreetcnJan 28 18:56 ET

Pharmacovigilance disintegrates CXO, what is the market concerned about?

It was only in December that the full-year forecast was lowered. What kind of medicine does Yakumin Biotech sell in gourds?

wallstreetcnDec 4, 2023 00:37 ET

WuXi AppTec GAAP EPS of RMB 0.94, Revenue of RMB 10.67B

Seeking AlphaOct 30, 2023 14:46 ET

“Yemao” Tongze Healthcare's revenue growth in the third quarter was close to stagnation, and net profit fell 5.58% year on year | Financial News

Tongce Medical's revenue for the first three quarters was 2.85 billion yuan, up 2.12% year on year; net profit to mother was 512 million yuan, a decrease of 0.67% year on year.

wallstreetcnOct 24, 2023 09:16 ET

There are not enough diet pills, Pharmacom announces another 60% increase in production capacity | Insight Research

Pharmaceutical Kangde announced today that its subsidiary Hequan Pharmaceutical will increase its peptide production capacity by 60%. At present, Hequan Pharmaceutical has begun a polypeptide production capacity expansion project for two production sites in Changzhou and Taixing. After the expansion is completed, Hequan Pharmaceutical will add multiple solid phase synthesis production lines for peptides. The new production capacity is expected to be put into use in December 2023. At that time, the volume of the peptide solid phase synthesis reactor will increase from the 20,000L originally planned to 32,000L. Previously, at the production site of Pharmaceutical Ming Kangde in Changzhou, WuXiTides put into operation two 2,000L polypeptide solid-phase synthesizers in April of this year, which means WuXiti

wallstreetcnSep 26, 2023 23:01 ET